EDGAR Filing Documents for 0001213900-23-056545

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001213900-23-056545

Filing Date

2023-07-13

Accepted

2023-07-12 19:49:06

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ea181611-s3_unicycivetherap.htm	S-3	241258
2	OPINION OF SHEPPARD, MULLIN, RICHTER & HAMPTON LLP AS TO THE LEGALITY OF THE SEC	ea181611ex5-1_unicycive.htm	EX-5.1	16104
3	CONSENT OF MAYER HOFFMAN MCCANN P.C	ea181611ex23-1_unicycive.htm	EX-23.1	1819
4	FILING FEE TABLE	ea181611ex-fee_unicycive.htm	EX-FILING FEES	12250
5	GRAPHIC	image_001.jpg	GRAPHIC	20382
6	GRAPHIC	image_002.jpg	GRAPHIC	10923
7	GRAPHIC	ex5-1_001.jpg	GRAPHIC	8544
	Complete submission text file	0001213900-23-056545.txt		327691

Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022

Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642

Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)